D.A. Davidson & Co’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

D.A. Davidson & Co’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,000	Closed	-$10K	–	2597
2016 Q3	$10K	Hold	4,000	–	–	﹤0.01%	2060
2016 Q2	$9K	Hold	4,000	–	–	﹤0.01%	2005
2016 Q1	$12K	Hold	4,000	–	–	﹤0.01%	1881
2015 Q4	$19K	Buy	+4,000	New	+$22.7K	﹤0.01%	1734

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

D.A. Davidson & Co's BDSI Position: Q4 2016 in Review

D.A. Davidson & Co sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2016, closing a stake of 4,000 shares — an estimated $10K sold.

D.A. Davidson & Co first reported a position in BDSI in Q4 2015 and held it in 4 quarters. The position peaked at $19K in Q4 2015. 77 funds tracked by Wall St. Rank hold BDSI as of Q4 2016.

D.A. Davidson & Co reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2016 after selling out during the quarter.
D.A. Davidson & Co sold 4,000 BioDelivery Sciences International, Inc. shares in Q4 2016, an estimated $10K.
D.A. Davidson & Co first reported a position in BioDelivery Sciences International, Inc. in Q4 2015 and held it in 4 quarters.
D.A. Davidson & Co's BioDelivery Sciences International, Inc. position peaked at $19K in Q4 2015.
77 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2016.

Based on D.A. Davidson & Co's 13F filing for Q4 2016, filed 15 Feb 2017.